What are the candidate groups for pharmacotherapeutic intervention to prevent asthma?
- 1 October 2000
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 11, 41-44
- https://doi.org/10.1034/j.1399-3038.2000.00510.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prophylactic treatment with loratadine versus cromolyn sodium in children with mild-to-moderate perennial allergic asthmaCurrent Therapeutic Research, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAACThe Lancet, 1998
- The development of allergy in high‐risk childrenClinical and Experimental Allergy, 1997
- Towards preventionThe Lancet, 1997
- Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1996
- Prevention of asthma with ketotifen in preasthmatic children: a three‐year follow‐up studyClinical and Experimental Allergy, 1995
- Asthma and Wheezing in the First Six Years of LifeNew England Journal of Medicine, 1995
- Risk factors in early childhood for the development of atopic diseasesAllergy, 1994
- Asthma: a follow up statement from an international paediatric asthma consensus group.Archives of Disease in Childhood, 1992